Budak-Alpdogan T - Search Results

1

Plitidepsin (Aplidin) is a potent inhibitor of diffuse large cell and Burkitt lymphoma and is synergistic with rituximab.

Barboza NM, Medina DJ, Budak-Alpdogan T, Aracil M, Jimeno JM, Bertino JR, Banerjee D. Barboza NM, et al. Cancer Biol Ther. 2012 Jan 15;13(2):114-22. doi: 10.4161/cbt.13.2.18876. Cancer Biol Ther. 2012. PMID: 22336911 Free PMC article.

2

Hematopoietic stem cell gene therapy with drug resistance genes: an update.

Budak-Alpdogan T, Banerjee D, Bertino JR. Budak-Alpdogan T, et al. Cancer Gene Ther. 2005 Nov;12(11):849-63. doi: 10.1038/sj.cgt.7700866. Cancer Gene Ther. 2005. PMID: 16037821 Review.

3

Retinoblastoma tumor suppressor gene expression determines the response to sequential flavopiridol and doxorubicin treatment in small-cell lung carcinoma.

Budak-Alpdogan T, Chen B, Warrier A, Medina DJ, Moore D, Bertino JR. Budak-Alpdogan T, et al. Clin Cancer Res. 2009 Feb 15;15(4):1232-40. doi: 10.1158/1078-0432.CCR-08-0810. Epub 2009 Jan 27. Clin Cancer Res. 2009. PMID: 19174488

4

Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancer.

Xie X, Kerrigan JE, Minko T, Garbuzenko O, Lee KC, Scarborough A, Abali EE, Budak-Alpdogan T, Johnson-Farley N, Banerjee D, Scotto KW, Bertino JR. Xie X, et al. Cancer Biol Ther. 2013 Aug;14(8):742-51. doi: 10.4161/cbt.25184. Epub 2013 Jun 3. Cancer Biol Ther. 2013. PMID: 23792570 Free PMC article.

5

Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene.

Budak-Alpdogan T, Alpdogan O, Banerjee D, Wang E, Moore MA, Bertino JR. Budak-Alpdogan T, et al. Mol Ther. 2004 Sep;10(3):574-84. doi: 10.1016/j.ymthe.2004.06.115. Mol Ther. 2004. PMID: 15336657 Free article.

6

Role of pemetrexed in non-small cell lung cancer.

Longo-Sorbello GS, Chen B, Budak-Alpdogan T, Bertino JR. Longo-Sorbello GS, et al. Cancer Invest. 2007 Feb;25(1):59-66. doi: 10.1080/07357900601130748. Cancer Invest. 2007. PMID: 17364559 Review.

7

Chemoprotection by transfer of resistance genes.

Budak-Alpdogan T, Bertino JR. Budak-Alpdogan T, et al. Methods Mol Biol. 2009;542:661-704. doi: 10.1007/978-1-59745-561-9_34. Methods Mol Biol. 2009. PMID: 19565927

8

Functional assessment of the engraftment potential of gammaretrovirus-modified CD34+ cells, using a short serum-free transduction protocol.

Budak-Alpdogan T, Przybylowski M, Gonen M, Sadelain M, Bertino J, Rivière I. Budak-Alpdogan T, et al. Hum Gene Ther. 2006 Jul;17(7):780-94. doi: 10.1089/hum.2006.17.780. Hum Gene Ther. 2006. PMID: 16839276

9

Enrichment of human prostate cancer cells with tumor initiating properties in mouse and zebrafish xenografts by differential adhesion.

Bansal N, Davis S, Tereshchenko I, Budak-Alpdogan T, Zhong H, Stein MN, Kim IY, Dipaola RS, Bertino JR, Sabaawy HE. Bansal N, et al. Prostate. 2014 Feb;74(2):187-200. doi: 10.1002/pros.22740. Epub 2013 Oct 24. Prostate. 2014. PMID: 24154958 Free PMC article.

10

Cobblestone-area forming cells derived from patients with mantle cell lymphoma are enriched for CD133+ tumor-initiating cells.

Medina DJ, Abass-Shereef J, Walton K, Goodell L, Aviv H, Strair RK, Budak-Alpdogan T. Medina DJ, et al. PLoS One. 2014 Apr 10;9(4):e91042. doi: 10.1371/journal.pone.0091042. eCollection 2014. PLoS One. 2014. PMID: 24722054 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters